Global Circular RNA Drugs Market Research Report 2026(Status and Outlook)
Circular RNA drugs refer to therapeutics that utilize circular RNA (circRNA) molecules as the active ingredient for treating various diseases. CircRNAs are naturally occurring, non-coding RNA molecules with a covalently closed-loop structure. They have gained significant attention for their potential as therapeutic agents due to their stability, resistance to exonucleases, and ability to regulate gene expression. CircRNA-based drugs may be used in gene therapy, cancer treatment, and other applications by leveraging their ability to modulate protein expression and cellular functions.
The global Circular RNA Drugs market size was estimated at USD 225.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 15.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Circular RNA Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Circular RNA Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Circular RNA Drugs market.
Global Circular RNA Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Orna Therapeutics
Torque Bio
Chimera Therapeutics
CirCode Bio
RiboX Therapeutics
Sail Biomedicines
Curemed Bio
Market Segmentation (by Type)
Marketing
Clinical
Market Segmentation (by Application)
Drugs
Vaccines
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Circular RNA Drugs Market
Overview of the regional outlook of the Circular RNA Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Circular RNA Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Circular RNA Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Circular RNA Drugs market size was estimated at USD 225.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 15.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Circular RNA Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Circular RNA Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Circular RNA Drugs market.
Global Circular RNA Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Orna Therapeutics
Torque Bio
Chimera Therapeutics
CirCode Bio
RiboX Therapeutics
Sail Biomedicines
Curemed Bio
Market Segmentation (by Type)
Marketing
Clinical
Market Segmentation (by Application)
Drugs
Vaccines
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Circular RNA Drugs Market
Overview of the regional outlook of the Circular RNA Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Circular RNA Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Circular RNA Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Circular RNA Drugs
1.2 Key Market Segments
1.2.1 Circular RNA Drugs Segment by Type
1.2.2 Circular RNA Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CIRCULAR RNA DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Circular RNA Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Circular RNA Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CIRCULAR RNA DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Circular RNA Drugs Product Life Cycle
3.3 Global Circular RNA Drugs Sales by Manufacturers (2020-2025)
3.4 Global Circular RNA Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Circular RNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Circular RNA Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Circular RNA Drugs Market Competitive Situation and Trends
3.8.1 Circular RNA Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Circular RNA Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CIRCULAR RNA DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Circular RNA Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CIRCULAR RNA DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Circular RNA Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Circular RNA Drugs Market
5.7 ESG Ratings of Leading Companies
6 CIRCULAR RNA DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Circular RNA Drugs Sales Market Share by Type (2020-2025)
6.3 Global Circular RNA Drugs Market Size by Type (2020-2025)
6.4 Global Circular RNA Drugs Price by Type (2020-2025)
7 CIRCULAR RNA DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Circular RNA Drugs Market Sales by Application (2020-2025)
7.3 Global Circular RNA Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Circular RNA Drugs Sales Growth Rate by Application (2020-2025)
8 CIRCULAR RNA DRUGS MARKET SALES BY REGION
8.1 Global Circular RNA Drugs Sales by Region
8.1.1 Global Circular RNA Drugs Sales by Region
8.1.2 Global Circular RNA Drugs Sales Market Share by Region
8.2 Global Circular RNA Drugs Market Size by Region
8.2.1 Global Circular RNA Drugs Market Size by Region
8.2.2 Global Circular RNA Drugs Market Size by Region
8.3 North America
8.3.1 North America Circular RNA Drugs Sales by Country
8.3.2 North America Circular RNA Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Circular RNA Drugs Sales by Country
8.4.2 Europe Circular RNA Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Circular RNA Drugs Sales by Region
8.5.2 Asia Pacific Circular RNA Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Circular RNA Drugs Sales by Country
8.6.2 South America Circular RNA Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Circular RNA Drugs Sales by Region
8.7.2 Middle East and Africa Circular RNA Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CIRCULAR RNA DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Circular RNA Drugs by Region(2020-2025)
9.2 Global Circular RNA Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Circular RNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Circular RNA Drugs Production
9.4.1 North America Circular RNA Drugs Production Growth Rate (2020-2025)
9.4.2 North America Circular RNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Circular RNA Drugs Production
9.5.1 Europe Circular RNA Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Circular RNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Circular RNA Drugs Production (2020-2025)
9.6.1 Japan Circular RNA Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Circular RNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Circular RNA Drugs Production (2020-2025)
9.7.1 China Circular RNA Drugs Production Growth Rate (2020-2025)
9.7.2 China Circular RNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Orna Therapeutics
10.1.1 Orna Therapeutics Basic Information
10.1.2 Orna Therapeutics Circular RNA Drugs Product Overview
10.1.3 Orna Therapeutics Circular RNA Drugs Product Market Performance
10.1.4 Orna Therapeutics Business Overview
10.1.5 Orna Therapeutics SWOT Analysis
10.1.6 Orna Therapeutics Recent Developments
10.2 Torque Bio
10.2.1 Torque Bio Basic Information
10.2.2 Torque Bio Circular RNA Drugs Product Overview
10.2.3 Torque Bio Circular RNA Drugs Product Market Performance
10.2.4 Torque Bio Business Overview
10.2.5 Torque Bio SWOT Analysis
10.2.6 Torque Bio Recent Developments
10.3 Chimera Therapeutics
10.3.1 Chimera Therapeutics Basic Information
10.3.2 Chimera Therapeutics Circular RNA Drugs Product Overview
10.3.3 Chimera Therapeutics Circular RNA Drugs Product Market Performance
10.3.4 Chimera Therapeutics Business Overview
10.3.5 Chimera Therapeutics SWOT Analysis
10.3.6 Chimera Therapeutics Recent Developments
10.4 CirCode Bio
10.4.1 CirCode Bio Basic Information
10.4.2 CirCode Bio Circular RNA Drugs Product Overview
10.4.3 CirCode Bio Circular RNA Drugs Product Market Performance
10.4.4 CirCode Bio Business Overview
10.4.5 CirCode Bio Recent Developments
10.5 RiboX Therapeutics
10.5.1 RiboX Therapeutics Basic Information
10.5.2 RiboX Therapeutics Circular RNA Drugs Product Overview
10.5.3 RiboX Therapeutics Circular RNA Drugs Product Market Performance
10.5.4 RiboX Therapeutics Business Overview
10.5.5 RiboX Therapeutics Recent Developments
10.6 Sail Biomedicines
10.6.1 Sail Biomedicines Basic Information
10.6.2 Sail Biomedicines Circular RNA Drugs Product Overview
10.6.3 Sail Biomedicines Circular RNA Drugs Product Market Performance
10.6.4 Sail Biomedicines Business Overview
10.6.5 Sail Biomedicines Recent Developments
10.7 Curemed Bio
10.7.1 Curemed Bio Basic Information
10.7.2 Curemed Bio Circular RNA Drugs Product Overview
10.7.3 Curemed Bio Circular RNA Drugs Product Market Performance
10.7.4 Curemed Bio Business Overview
10.7.5 Curemed Bio Recent Developments
11 CIRCULAR RNA DRUGS MARKET FORECAST BY REGION
11.1 Global Circular RNA Drugs Market Size Forecast
11.2 Global Circular RNA Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Circular RNA Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Circular RNA Drugs Market Size Forecast by Region
11.2.4 South America Circular RNA Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Circular RNA Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Circular RNA Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Circular RNA Drugs by Type (2026-2035)
12.1.2 Global Circular RNA Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Circular RNA Drugs by Type (2026-2035)
12.2 Global Circular RNA Drugs Market Forecast by Application (2026-2035)
12.2.1 Global Circular RNA Drugs Sales (K MT) Forecast by Application
12.2.2 Global Circular RNA Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Circular RNA Drugs
1.2 Key Market Segments
1.2.1 Circular RNA Drugs Segment by Type
1.2.2 Circular RNA Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CIRCULAR RNA DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Circular RNA Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Circular RNA Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CIRCULAR RNA DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Circular RNA Drugs Product Life Cycle
3.3 Global Circular RNA Drugs Sales by Manufacturers (2020-2025)
3.4 Global Circular RNA Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Circular RNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Circular RNA Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Circular RNA Drugs Market Competitive Situation and Trends
3.8.1 Circular RNA Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Circular RNA Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CIRCULAR RNA DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Circular RNA Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CIRCULAR RNA DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Circular RNA Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Circular RNA Drugs Market
5.7 ESG Ratings of Leading Companies
6 CIRCULAR RNA DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Circular RNA Drugs Sales Market Share by Type (2020-2025)
6.3 Global Circular RNA Drugs Market Size by Type (2020-2025)
6.4 Global Circular RNA Drugs Price by Type (2020-2025)
7 CIRCULAR RNA DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Circular RNA Drugs Market Sales by Application (2020-2025)
7.3 Global Circular RNA Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Circular RNA Drugs Sales Growth Rate by Application (2020-2025)
8 CIRCULAR RNA DRUGS MARKET SALES BY REGION
8.1 Global Circular RNA Drugs Sales by Region
8.1.1 Global Circular RNA Drugs Sales by Region
8.1.2 Global Circular RNA Drugs Sales Market Share by Region
8.2 Global Circular RNA Drugs Market Size by Region
8.2.1 Global Circular RNA Drugs Market Size by Region
8.2.2 Global Circular RNA Drugs Market Size by Region
8.3 North America
8.3.1 North America Circular RNA Drugs Sales by Country
8.3.2 North America Circular RNA Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Circular RNA Drugs Sales by Country
8.4.2 Europe Circular RNA Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Circular RNA Drugs Sales by Region
8.5.2 Asia Pacific Circular RNA Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Circular RNA Drugs Sales by Country
8.6.2 South America Circular RNA Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Circular RNA Drugs Sales by Region
8.7.2 Middle East and Africa Circular RNA Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CIRCULAR RNA DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Circular RNA Drugs by Region(2020-2025)
9.2 Global Circular RNA Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Circular RNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Circular RNA Drugs Production
9.4.1 North America Circular RNA Drugs Production Growth Rate (2020-2025)
9.4.2 North America Circular RNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Circular RNA Drugs Production
9.5.1 Europe Circular RNA Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Circular RNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Circular RNA Drugs Production (2020-2025)
9.6.1 Japan Circular RNA Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Circular RNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Circular RNA Drugs Production (2020-2025)
9.7.1 China Circular RNA Drugs Production Growth Rate (2020-2025)
9.7.2 China Circular RNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Orna Therapeutics
10.1.1 Orna Therapeutics Basic Information
10.1.2 Orna Therapeutics Circular RNA Drugs Product Overview
10.1.3 Orna Therapeutics Circular RNA Drugs Product Market Performance
10.1.4 Orna Therapeutics Business Overview
10.1.5 Orna Therapeutics SWOT Analysis
10.1.6 Orna Therapeutics Recent Developments
10.2 Torque Bio
10.2.1 Torque Bio Basic Information
10.2.2 Torque Bio Circular RNA Drugs Product Overview
10.2.3 Torque Bio Circular RNA Drugs Product Market Performance
10.2.4 Torque Bio Business Overview
10.2.5 Torque Bio SWOT Analysis
10.2.6 Torque Bio Recent Developments
10.3 Chimera Therapeutics
10.3.1 Chimera Therapeutics Basic Information
10.3.2 Chimera Therapeutics Circular RNA Drugs Product Overview
10.3.3 Chimera Therapeutics Circular RNA Drugs Product Market Performance
10.3.4 Chimera Therapeutics Business Overview
10.3.5 Chimera Therapeutics SWOT Analysis
10.3.6 Chimera Therapeutics Recent Developments
10.4 CirCode Bio
10.4.1 CirCode Bio Basic Information
10.4.2 CirCode Bio Circular RNA Drugs Product Overview
10.4.3 CirCode Bio Circular RNA Drugs Product Market Performance
10.4.4 CirCode Bio Business Overview
10.4.5 CirCode Bio Recent Developments
10.5 RiboX Therapeutics
10.5.1 RiboX Therapeutics Basic Information
10.5.2 RiboX Therapeutics Circular RNA Drugs Product Overview
10.5.3 RiboX Therapeutics Circular RNA Drugs Product Market Performance
10.5.4 RiboX Therapeutics Business Overview
10.5.5 RiboX Therapeutics Recent Developments
10.6 Sail Biomedicines
10.6.1 Sail Biomedicines Basic Information
10.6.2 Sail Biomedicines Circular RNA Drugs Product Overview
10.6.3 Sail Biomedicines Circular RNA Drugs Product Market Performance
10.6.4 Sail Biomedicines Business Overview
10.6.5 Sail Biomedicines Recent Developments
10.7 Curemed Bio
10.7.1 Curemed Bio Basic Information
10.7.2 Curemed Bio Circular RNA Drugs Product Overview
10.7.3 Curemed Bio Circular RNA Drugs Product Market Performance
10.7.4 Curemed Bio Business Overview
10.7.5 Curemed Bio Recent Developments
11 CIRCULAR RNA DRUGS MARKET FORECAST BY REGION
11.1 Global Circular RNA Drugs Market Size Forecast
11.2 Global Circular RNA Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Circular RNA Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Circular RNA Drugs Market Size Forecast by Region
11.2.4 South America Circular RNA Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Circular RNA Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Circular RNA Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Circular RNA Drugs by Type (2026-2035)
12.1.2 Global Circular RNA Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Circular RNA Drugs by Type (2026-2035)
12.2 Global Circular RNA Drugs Market Forecast by Application (2026-2035)
12.2.1 Global Circular RNA Drugs Sales (K MT) Forecast by Application
12.2.2 Global Circular RNA Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Circular RNA Drugs Market Size by Type (M USD)
Table 4. Global Circular RNA Drugs Market Size by Application
Table 5. Circular RNA Drugs Market Size Comparison by Region (M USD)
Table 6. Global Circular RNA Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Circular RNA Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Circular RNA Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Circular RNA Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circular RNA Drugs as of 2025)
Table 11. Global Market Circular RNA Drugs Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Circular RNA Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Circular RNA Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Circular RNA Drugs Sales by Type (K MT)
Table 27. Global Circular RNA Drugs Market Size by Type (M USD)
Table 28. Global Circular RNA Drugs Sales (K MT) by Type (2020-2025)
Table 29. Global Circular RNA Drugs Sales Market Share by Type (2020-2025)
Table 30. Global Circular RNA Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global Circular RNA Drugs Market Share by Type (2020-2025)
Table 32. Global Circular RNA Drugs Price (USD/KG) by Type (2020-2025)
Table 33. Global Circular RNA Drugs Sales (K MT) by Application
Table 34. Global Circular RNA Drugs Market Size by Application
Table 35. Global Circular RNA Drugs Sales by Application (2020-2025) & (K MT)
Table 36. Global Circular RNA Drugs Sales Market Share by Application (2020-2025)
Table 37. Global Circular RNA Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global Circular RNA Drugs Market Share by Application (2020-2025)
Table 39. Global Circular RNA Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global Circular RNA Drugs Sales by Region (2020-2025) & (K MT)
Table 41. Global Circular RNA Drugs Sales Market Share by Region (2020-2025)
Table 42. Global Circular RNA Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global Circular RNA Drugs Market Size by Region (2020-2025)
Table 44. North America Circular RNA Drugs Sales by Country (2020-2025) & (K MT)
Table 45. North America Circular RNA Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Circular RNA Drugs Sales by Country (2020-2025) & (K MT)
Table 47. Europe Circular RNA Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Circular RNA Drugs Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Circular RNA Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America Circular RNA Drugs Sales by Country (2020-2025) & (K MT)
Table 51. South America Circular RNA Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Circular RNA Drugs Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Circular RNA Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global Circular RNA Drugs Production (K MT) by Region(2020-2025)
Table 55. Global Circular RNA Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Circular RNA Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global Circular RNA Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Circular RNA Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Circular RNA Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Circular RNA Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Circular RNA Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Orna Therapeutics Basic Information
Table 63. Orna Therapeutics Circular RNA Drugs Product Overview
Table 64. Orna Therapeutics Circular RNA Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Orna Therapeutics Business Overview
Table 66. Orna Therapeutics SWOT Analysis
Table 67. Orna Therapeutics Recent Developments
Table 68. Torque Bio Basic Information
Table 69. Torque Bio Circular RNA Drugs Product Overview
Table 70. Torque Bio Circular RNA Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Torque Bio Business Overview
Table 72. Torque Bio SWOT Analysis
Table 73. Torque Bio Recent Developments
Table 74. Chimera Therapeutics Basic Information
Table 75. Chimera Therapeutics Circular RNA Drugs Product Overview
Table 76. Chimera Therapeutics Circular RNA Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Chimera Therapeutics Business Overview
Table 78. Chimera Therapeutics SWOT Analysis
Table 79. Chimera Therapeutics Recent Developments
Table 80. CirCode Bio Basic Information
Table 81. CirCode Bio Circular RNA Drugs Product Overview
Table 82. CirCode Bio Circular RNA Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. CirCode Bio Business Overview
Table 84. CirCode Bio Recent Developments
Table 85. RiboX Therapeutics Basic Information
Table 86. RiboX Therapeutics Circular RNA Drugs Product Overview
Table 87. RiboX Therapeutics Circular RNA Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. RiboX Therapeutics Business Overview
Table 89. RiboX Therapeutics Recent Developments
Table 90. Sail Biomedicines Basic Information
Table 91. Sail Biomedicines Circular RNA Drugs Product Overview
Table 92. Sail Biomedicines Circular RNA Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Sail Biomedicines Business Overview
Table 94. Sail Biomedicines Recent Developments
Table 95. Curemed Bio Basic Information
Table 96. Curemed Bio Circular RNA Drugs Product Overview
Table 97. Curemed Bio Circular RNA Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Curemed Bio Business Overview
Table 99. Curemed Bio Recent Developments
Table 100. Global Circular RNA Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 101. Global Circular RNA Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 102. North America Circular RNA Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 103. North America Circular RNA Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 104. Europe Circular RNA Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 105. Europe Circular RNA Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 106. Asia Pacific Circular RNA Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 107. Asia Pacific Circular RNA Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 108. South America Circular RNA Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 109. South America Circular RNA Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 110. Middle East and Africa Circular RNA Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 111. Middle East and Africa Circular RNA Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 112. Global Circular RNA Drugs Sales Forecast by Type (2026-2035) & (K MT)
Table 113. Global Circular RNA Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 114. Global Circular RNA Drugs Price Forecast by Type (2026-2035) & (USD/KG)
Table 115. Global Circular RNA Drugs Sales (K MT) Forecast by Application (2026-2035)
Table 116. Global Circular RNA Drugs Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Circular RNA Drugs Market Size by Type (M USD)
Table 4. Global Circular RNA Drugs Market Size by Application
Table 5. Circular RNA Drugs Market Size Comparison by Region (M USD)
Table 6. Global Circular RNA Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Circular RNA Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Circular RNA Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Circular RNA Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circular RNA Drugs as of 2025)
Table 11. Global Market Circular RNA Drugs Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Circular RNA Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Circular RNA Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Circular RNA Drugs Sales by Type (K MT)
Table 27. Global Circular RNA Drugs Market Size by Type (M USD)
Table 28. Global Circular RNA Drugs Sales (K MT) by Type (2020-2025)
Table 29. Global Circular RNA Drugs Sales Market Share by Type (2020-2025)
Table 30. Global Circular RNA Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global Circular RNA Drugs Market Share by Type (2020-2025)
Table 32. Global Circular RNA Drugs Price (USD/KG) by Type (2020-2025)
Table 33. Global Circular RNA Drugs Sales (K MT) by Application
Table 34. Global Circular RNA Drugs Market Size by Application
Table 35. Global Circular RNA Drugs Sales by Application (2020-2025) & (K MT)
Table 36. Global Circular RNA Drugs Sales Market Share by Application (2020-2025)
Table 37. Global Circular RNA Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global Circular RNA Drugs Market Share by Application (2020-2025)
Table 39. Global Circular RNA Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global Circular RNA Drugs Sales by Region (2020-2025) & (K MT)
Table 41. Global Circular RNA Drugs Sales Market Share by Region (2020-2025)
Table 42. Global Circular RNA Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global Circular RNA Drugs Market Size by Region (2020-2025)
Table 44. North America Circular RNA Drugs Sales by Country (2020-2025) & (K MT)
Table 45. North America Circular RNA Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Circular RNA Drugs Sales by Country (2020-2025) & (K MT)
Table 47. Europe Circular RNA Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Circular RNA Drugs Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Circular RNA Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America Circular RNA Drugs Sales by Country (2020-2025) & (K MT)
Table 51. South America Circular RNA Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Circular RNA Drugs Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Circular RNA Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global Circular RNA Drugs Production (K MT) by Region(2020-2025)
Table 55. Global Circular RNA Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Circular RNA Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global Circular RNA Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Circular RNA Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Circular RNA Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Circular RNA Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Circular RNA Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Orna Therapeutics Basic Information
Table 63. Orna Therapeutics Circular RNA Drugs Product Overview
Table 64. Orna Therapeutics Circular RNA Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Orna Therapeutics Business Overview
Table 66. Orna Therapeutics SWOT Analysis
Table 67. Orna Therapeutics Recent Developments
Table 68. Torque Bio Basic Information
Table 69. Torque Bio Circular RNA Drugs Product Overview
Table 70. Torque Bio Circular RNA Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Torque Bio Business Overview
Table 72. Torque Bio SWOT Analysis
Table 73. Torque Bio Recent Developments
Table 74. Chimera Therapeutics Basic Information
Table 75. Chimera Therapeutics Circular RNA Drugs Product Overview
Table 76. Chimera Therapeutics Circular RNA Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Chimera Therapeutics Business Overview
Table 78. Chimera Therapeutics SWOT Analysis
Table 79. Chimera Therapeutics Recent Developments
Table 80. CirCode Bio Basic Information
Table 81. CirCode Bio Circular RNA Drugs Product Overview
Table 82. CirCode Bio Circular RNA Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. CirCode Bio Business Overview
Table 84. CirCode Bio Recent Developments
Table 85. RiboX Therapeutics Basic Information
Table 86. RiboX Therapeutics Circular RNA Drugs Product Overview
Table 87. RiboX Therapeutics Circular RNA Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. RiboX Therapeutics Business Overview
Table 89. RiboX Therapeutics Recent Developments
Table 90. Sail Biomedicines Basic Information
Table 91. Sail Biomedicines Circular RNA Drugs Product Overview
Table 92. Sail Biomedicines Circular RNA Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Sail Biomedicines Business Overview
Table 94. Sail Biomedicines Recent Developments
Table 95. Curemed Bio Basic Information
Table 96. Curemed Bio Circular RNA Drugs Product Overview
Table 97. Curemed Bio Circular RNA Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Curemed Bio Business Overview
Table 99. Curemed Bio Recent Developments
Table 100. Global Circular RNA Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 101. Global Circular RNA Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 102. North America Circular RNA Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 103. North America Circular RNA Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 104. Europe Circular RNA Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 105. Europe Circular RNA Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 106. Asia Pacific Circular RNA Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 107. Asia Pacific Circular RNA Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 108. South America Circular RNA Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 109. South America Circular RNA Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 110. Middle East and Africa Circular RNA Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 111. Middle East and Africa Circular RNA Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 112. Global Circular RNA Drugs Sales Forecast by Type (2026-2035) & (K MT)
Table 113. Global Circular RNA Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 114. Global Circular RNA Drugs Price Forecast by Type (2026-2035) & (USD/KG)
Table 115. Global Circular RNA Drugs Sales (K MT) Forecast by Application (2026-2035)
Table 116. Global Circular RNA Drugs Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Circular RNA Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Circular RNA Drugs Market Size (M USD), 2025-2035
Figure 5. Global Circular RNA Drugs Market Size (M USD) (2020-2035)
Figure 6. Global Circular RNA Drugs Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Circular RNA Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Circular RNA Drugs Product Life Cycle
Figure 13. Circular RNA Drugs Sales Share by Manufacturers in 2025
Figure 14. Global Circular RNA Drugs Revenue Share by Manufacturers in 2025
Figure 15. Circular RNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Circular RNA Drugs Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Circular RNA Drugs Revenue in 2025
Figure 18. Industry Chain Map of Circular RNA Drugs
Figure 19. Global Circular RNA Drugs Market PEST Analysis
Figure 20. Global Circular RNA Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Circular RNA Drugs Market Share by Type
Figure 27. Sales Market Share of Circular RNA Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Circular RNA Drugs by Type in 2025
Figure 29. Market Share of Circular RNA Drugs by Type (2020-2025)
Figure 30. Market Share of Circular RNA Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Circular RNA Drugs Market Share by Application
Figure 33. Global Circular RNA Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Circular RNA Drugs Sales Market Share by Application in 2025
Figure 35. Global Circular RNA Drugs Market Share by Application (2020-2025)
Figure 36. Global Circular RNA Drugs Market Share by Application in 2025
Figure 37. Global Circular RNA Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Circular RNA Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Circular RNA Drugs Market Size by Region (2020-2025)
Figure 40. North America Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Circular RNA Drugs Sales Market Share by Country in 2024
Figure 43. North America Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Circular RNA Drugs Market Size by Country in 2024
Figure 45. U.S. Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Circular RNA Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Circular RNA Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Circular RNA Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Circular RNA Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Circular RNA Drugs Sales Market Share by Country in 2024
Figure 53. Europe Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Circular RNA Drugs Market Size by Country in 2024
Figure 55. Germany Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Circular RNA Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Circular RNA Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Circular RNA Drugs Market Size by Region in 2024
Figure 68. China Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Circular RNA Drugs Sales and Growth Rate (K MT)
Figure 79. South America Circular RNA Drugs Sales Market Share by Country in 2024
Figure 80. South America Circular RNA Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Circular RNA Drugs Market Size by Country in 2024
Figure 82. Brazil Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Circular RNA Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Circular RNA Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Circular RNA Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Circular RNA Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Circular RNA Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Circular RNA Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Circular RNA Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Circular RNA Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China Circular RNA Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Circular RNA Drugs Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Circular RNA Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Circular RNA Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Circular RNA Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global Circular RNA Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global Circular RNA Drugs Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Circular RNA Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Circular RNA Drugs Market Size (M USD), 2025-2035
Figure 5. Global Circular RNA Drugs Market Size (M USD) (2020-2035)
Figure 6. Global Circular RNA Drugs Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Circular RNA Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Circular RNA Drugs Product Life Cycle
Figure 13. Circular RNA Drugs Sales Share by Manufacturers in 2025
Figure 14. Global Circular RNA Drugs Revenue Share by Manufacturers in 2025
Figure 15. Circular RNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Circular RNA Drugs Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Circular RNA Drugs Revenue in 2025
Figure 18. Industry Chain Map of Circular RNA Drugs
Figure 19. Global Circular RNA Drugs Market PEST Analysis
Figure 20. Global Circular RNA Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Circular RNA Drugs Market Share by Type
Figure 27. Sales Market Share of Circular RNA Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Circular RNA Drugs by Type in 2025
Figure 29. Market Share of Circular RNA Drugs by Type (2020-2025)
Figure 30. Market Share of Circular RNA Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Circular RNA Drugs Market Share by Application
Figure 33. Global Circular RNA Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Circular RNA Drugs Sales Market Share by Application in 2025
Figure 35. Global Circular RNA Drugs Market Share by Application (2020-2025)
Figure 36. Global Circular RNA Drugs Market Share by Application in 2025
Figure 37. Global Circular RNA Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Circular RNA Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Circular RNA Drugs Market Size by Region (2020-2025)
Figure 40. North America Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Circular RNA Drugs Sales Market Share by Country in 2024
Figure 43. North America Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Circular RNA Drugs Market Size by Country in 2024
Figure 45. U.S. Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Circular RNA Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Circular RNA Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Circular RNA Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Circular RNA Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Circular RNA Drugs Sales Market Share by Country in 2024
Figure 53. Europe Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Circular RNA Drugs Market Size by Country in 2024
Figure 55. Germany Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Circular RNA Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Circular RNA Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Circular RNA Drugs Market Size by Region in 2024
Figure 68. China Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Circular RNA Drugs Sales and Growth Rate (K MT)
Figure 79. South America Circular RNA Drugs Sales Market Share by Country in 2024
Figure 80. South America Circular RNA Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Circular RNA Drugs Market Size by Country in 2024
Figure 82. Brazil Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Circular RNA Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Circular RNA Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Circular RNA Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Circular RNA Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Circular RNA Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Circular RNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Circular RNA Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Circular RNA Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Circular RNA Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Circular RNA Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China Circular RNA Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Circular RNA Drugs Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Circular RNA Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Circular RNA Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Circular RNA Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global Circular RNA Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global Circular RNA Drugs Market Share Forecast by Application (2026-2035)
